Endotoxin Testing in Peptides: Why It Matters for Research

The purity of a peptide indicates whether the vial has the correct substance. The testing for endotoxins tells whether the vial has microbiological residue which can cause an inflammatory reaction when the product is used in experimental work such as injections. These questions are dissimilar, and the Certificate of Analysis which gives only the negative half of the answer leaves a significant gap for any person working with injectable products.

What Are Endotoxins?

Endotoxins are lipopolysaccharide (LPS) molecules associated with the outer membrane of Gram-negative microorganisms. When the bacteria die, tiny pieces of the outer membrane are freed into the environment. Unlike live bacteria, endotoxins are resistant to autoclaving or standard cleaning processes. There are heat-stable and can survive in water, on glass, or in freeze-dried materials long after the bacteria have died.

In biological systems, very small amounts of endotoxin are enough to trigger a powerful immune reaction. So parenteral drugs (injectables) have to undergo endotoxin testing, as this is a regulator's obligation. The permissible amount of endotoxin present in pharmaceuticals is measured in endotoxin units (EU) and is a very low limit.

The LAL Assay Explained

LAL or Limulus Amebocyte Lysate test is an important tool that can detect and monitor endotoxins. It relies on amebocytes, a type of white blood cells of horseshoe crab, Limulus polyphemus. The presence of endotoxins in this lysate gives a rise to clotting process that can be assayed in multiple ways.

The article FDA's guidance on pyrogen and endotoxin testing talks about the USP Chapter 85 which describes the different LAL methods.

A new variant of the LAL method uses recombinant Factor C (rFC), that is, a synthetic type of the protein that initiates the coagulation cascade in horseshoe crab blood. RFC does not require catching horseshoe crabs, which prevents the development of false positives due to interference with beta-glucan. Both the European Pharmacopoeia and the FDA have accepted the methods based on rFC. Although rFC is gaining popularity, the LAL test is still the most common technique used in the certificate of analysis (COA) of research peptides.

Why Researchers Check for Endotoxins

Peptides that are marketed as freeze-dried powders are not regulated by the FDA as medical drugs. No law mandates the peptide supplier to conduct any tests for endotoxins. However, in practice, many customers dissolve these products and use them in their research, which involved injection into live animals or in cases where any endotoxin could contaminate the results of the research.

For injectable pharmaceutical products, USP Chapter 85 sets limits that vary by route of administration and dosing. A general threshold of 5 EU per kilogram of body weight per hour is applied to most parenteral drugs. For intrathecal (spinal) administration, the limit drops to 0.2 EU/kg/hr. For research peptides, which fall outside pharmaceutical regulation, these limits serve as useful reference points rather than binding requirements.

Real Peptides includes endotoxin data on the Certificates of Analysis published on each product page. The reported level of less than 0.1 EU per milligram is well below the threshold that would be concerning for most research applications. The testing is performed by Kovera Labs using the LAL assay method.

Which Vendors Test for Endotoxins

PeptideGod does not publish endotoxin data on its product pages or provide COAs with this information. This does not confirm the presence of endotoxins in their products. It means the buyer has no way to verify endotoxin levels independently.

When reading a Certificate of Analysis, look for the following. The test should be identified as LAL (Limulus Amebocyte Lysate) or BET (Bacterial Endotoxins Test). The result should be expressed in EU/mg or EU/mL. A result of less than 0.1 EU/mg is typical for well-manufactured research peptides. The sensitivity of the assay should be stated (this is the minimum detectable level). The lab performing the test should be named.

If the COA lists only HPLC purity and mass spec identity but omits endotoxin data, the product may still be low in endotoxins. The information is simply not available to evaluate. For research involving injection, this gap is worth noting.

When the certificate of analysis (COA) mentions only the purity by high-performance liquid chromatography (HPLC) and molecular weight by mass spectrometry but does not reference any information on endotoxin levels, it can be assumed that the product is low in endotoxins, although no information is available to support this. This absence of data may be important in regards to the researchers who do experiments involving injection.